A large-scale somatic mutation study demonstrated that in approximately 450 tumors, comprising breast, lung, ovarian, pancreatic, and prostate cancer, the SPOP gene was highly mutated in prostate cancer (Kan et al., 2010). Here, SPOP is linked to prostate carcinoma.